Newsroom

GHENT, Belgique & TOKYO--(BUSINESS WIRE)--H.U. Group Holdings Inc. et sa filiale entièrement détenue, Fujirebio, ont annoncé aujourd’hui que Santé Canada avait délivré des autorisations de mise sur le marché de dispositifs médicaux de classe II (MDL) pour les tests « Lumipulse G NfL Blood » et « Lumipulse G pTau 217 Plasma », destinés à être utilisés sur la plateforme d’immunoanalyse entièrement automatisée LUMIPULSE® G sur le marché canadien. « L’autorisation des tests Lumipulse G NfL Blood et...

PITTSBURGH--(BUSINESS WIRE)--Rimsys announces Market Access, a new AI-native product that helps regulated product companies assess entering a market before committing resources....

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, Sept. 14–16, 2026, in New York....

BUTTE, Mont.--(BUSINESS WIRE)--Silver Bow Mining reports 994.2 g/t AgEq over 4.0 m at the Rainbow Block in Butte, Montana, including 1,586.1 g/t AgEq over 2.3 m....

OSLO, Norway & BOSTON--(BUSINESS WIRE)--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout...

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trus...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) expects to publish the second quarter select and half-year 2026 unaudited financial results on 3 September 2026, before market open. Management will host a conference call at 14:00 Central European Time (08:00 US Eastern Time) the same day, accessible via the Polestar Investor Relations website. To register and join the call, please use this link https://edge.media-server.com/mmc/p/czg84qrx/ or follow the instructions available under...

BOSTON--(BUSINESS WIRE)--Great Hill Partners (“Great Hill”), a private equity firm that invests in high-growth, disruptive companies, today announced a strategic investment in Aurenity (the “Company”), a technology-enabled excess & surplus (“E&S”) managing general agent (“MGA”). Agman, Aurenity's founding investor, and the Company’s management team will retain a significant portion of their equity stakes in connection with the transaction. Financial terms were not disclosed. Great Hill'...